These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 21258052
1. Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses. Marchand-Janssen C, Loulergue P, Mouthon L, Mahr A, Blanche P, Deforges L, Lebon P, Cohen P, Pagnoux C, Le Guern V, Bienvenu B, Aouba A, Guillevin L, Launay O. Rheumatology (Oxford); 2011 Jun; 50(6):1099-105. PubMed ID: 21258052 [Abstract] [Full Text] [Related]
2. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history. Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O. Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810 [Abstract] [Full Text] [Related]
3. Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake. Skowronski DM, Pielak K, Remple VP, Halperin BA, Patrick DM, Naus M, McIntyre C. Vaccine; 2004 Dec 02; 23(3):353-61. PubMed ID: 15530680 [Abstract] [Full Text] [Related]
4. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T, Lavigne P. Vaccine; 2012 Mar 30; 30(16):2647-53. PubMed ID: 22353673 [Abstract] [Full Text] [Related]
5. [New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria]. Siegrist CA. Rev Med Suisse; 2012 Jan 18; 8(324):125-8. PubMed ID: 23185823 [Abstract] [Full Text] [Related]
6. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov. Pediatrics; 2005 Aug 18; 116(2):e285-94. PubMed ID: 16061582 [Abstract] [Full Text] [Related]
7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM. Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526 [Abstract] [Full Text] [Related]
12. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. P N G Med J; 2001 May 25; 44(1-2):6-16. PubMed ID: 12418673 [Abstract] [Full Text] [Related]
14. [Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on the immunity of pertussis, diphtheria and tetanus. 2. Observations during the intervals from the initial immunization to the time of booster dose and the effects of successive immunization]. Miura S. Nihon Shonika Gakkai Zasshi; 1968 Jun 25; 72(6):782-99. PubMed ID: 5749511 [No Abstract] [Full Text] [Related]
19. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain]. González López A, Arístegui Fernández J, Díez-Delgado J, Dal-Ré Saavedra R. An Esp Pediatr; 1998 Feb 25; 48(2):132-7. PubMed ID: 9577019 [Abstract] [Full Text] [Related]